dc.contributor.author |
Lazaris, A |
en |
dc.contributor.author |
Theodoropoulos, G |
en |
dc.contributor.author |
Davaris, P |
en |
dc.contributor.author |
Panoussopoulos, D |
en |
dc.contributor.author |
Nakopoulou, L |
en |
dc.contributor.author |
Kittas, C |
en |
dc.contributor.author |
Golematis, B |
en |
dc.date.accessioned |
2014-06-06T06:42:54Z |
|
dc.date.available |
2014-06-06T06:42:54Z |
|
dc.date.issued |
1995 |
en |
dc.identifier.uri |
http://dx.doi.org/10.1007/BF02048033 |
en |
dc.identifier.uri |
http://62.217.125.90/xmlui/handle/123456789/871 |
|
dc.subject |
Colorectal Cancer |
en |
dc.subject |
Colorectal Carcinoma |
en |
dc.subject |
Overall Survival |
en |
dc.subject |
Patient Survival |
en |
dc.subject |
Tumor Immunology |
en |
dc.subject |
Heat Shock Protein |
en |
dc.title |
Heat shock protein 70 and HLA-DR molecules tissue expression |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1007/BF02048033 |
en |
heal.publicationDate |
1995 |
en |
heal.abstract |
PURPOSE: The expression of 70,000-Da heat shock protein (HSP 70) and HLA-DR molecules on cancer cells influences immunologic mechanisms that may be of some prognostic significance. The purpose of this study was to examine the relationship among immunohistochemical HSP 70, HLA-DR expression, and clinicopathologic tumor variables, as well as patient survival in a series of 128 colorectal carcinomas. METHOD: A |
en |
heal.journalName |
Diseases of The Colon & Rectum |
en |
dc.identifier.doi |
10.1007/BF02048033 |
en |